Why the study?
Does polypharmacy increase the risk of dementia in community-dwelling elderly patients?
Population
11,124 community-dwelling elderly patients aged ≥65 years with no prior hospitalization history from the…
Comparison
Polypharmacy vs Non-polypharmacy
Design
Case-control
Follow-up
2-year look-back period
Authors
Loading...
May support deprescribing trials in older adults; leaves open causal role in dementia incidence.
Does polypharmacy increase the risk of dementia in community-dwelling elderly patients?
Polypharmacy is significantly associated with an increased risk of dementia in the elderly, highlighting the need to limit inappropriate medication prescriptions.
Park et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: